Back to top
more

Endologix, Inc. (ELGX)

(Delayed Data from NSDQ)

$6.50 USD

6.50
664,018

+0.18 (2.85%)

Updated May 3, 2019 04:00 PM ET

After-Market: $6.51 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

Endologix, Inc. [ELGX]

Reports for Purchase

Showing records 1 - 20 ( 52 total )

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 1

10/08/2019

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for ELGX

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 2

12/18/2012

Company Report

Pages: 4

Dropping Coverage.

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 3

10/26/2012

Company Report

Pages: 5

Q3 RESULTS IN-LINE WITH EXPECTATIONS

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 4

10/23/2012

Company Report

Pages: 6

Panel Meeting At TCT Demonsttrated Solid Performance Of Company''s 3 New Product Platforms

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 25.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 5

09/18/2012

Company Report

Pages: 5

FINE TUNING Q4 AND 2013 ESTS

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 6

09/11/2012

Company Report

Pages: 6

REITS BUY ON NEW PRODUCT APPROVALS IN EUROPE

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 25.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 7

07/27/2012

Company Report

Pages: 5

Reits Buy On New Product Pipeline and CF Positive in Q4 2012

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 8

07/24/2012

Company Report

Pages: 5

ANTICIPATE IN-LINE Q2

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 9

04/27/2012

Company Report

Pages: 5

REVENUE GROWTH HANDLY EXCEEDS EXPECTIONS

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 10

04/24/2012

Company Report

Pages: 5

TYPICAL SEASONALITY

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 11

04/09/2012

Company Report

Pages: 5

REITERATE BUY ON NEW PROD. FLOW & GOING DIRECT IN EUROPE

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 12

03/26/2012

Industry Report

Pages: 10

Medical Device-notes from first annual Irvine/San Diago " Bus Tour "This report contains brief updates on the following: ELGX, DXCM, CYTX, GPRO, NUVA, RMD, ALR, MASI, SGNT. These companies are covered in more detail in separate Daily Notes and/or Company Reports.

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 25.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 13

02/22/2012

Company Report

Pages: 5

Q4 REVS SLIGHTLY BELOW EST

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 14

02/22/2012

Company Report

Pages: 7

Inline Quarter; Strong Guidance for 2012; Raising FV to $15

Provider: WEDBUSH SECURITIES INC.

Analyst: NASH D

Price: 25.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 15

02/21/2012

Company Report

Pages: 5

EXPECT IN LINE QUARTERLY LOSS

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 16

02/09/2012

Daily Note

Pages: 4

Completes Enrollment of PEVAR Trial; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: NASH D

Price: 10.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 17

01/06/2012

Industry Report

Pages: 37

LIFE SCIENCES: 2012 Life Sciences and Healthcare Preview: Macro and Sector Trends; Catalysts; Top Picks

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 18

12/20/2011

Daily Note

Pages: 5

Recap of Expert Call on AAA Repair Device Landscape; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: NASH D

Price: 10.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 19

11/14/2011

Industry Report

Pages: 8

Bucking Headwinds - Three Medical Device Companies To Ride Into The New Year

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 25.00

Research Provided by a Third Party

Company: Endologix, Inc.

Industry: Medical - Dental Supplies

Record: 20

10/28/2011

Company Report

Pages: 5

Q3 Beats Expectations - BUY

Provider: CAPSTONE INVESTMENTS

Analyst: PUTNAM J

Price: 10.00

Research Provided by a Third Party
// eof